{"id":"https://openalex.org/A5009504781","orcid":null,"observed_orcids":[],"display_name":"S Ghabri","raw_author_names":["S Ghabri","Salah Ghabri"],"full_name":"S Ghabri","works_count":5,"cited_by_count":1,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5009504781","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210107631","ror":"https://ror.org/01qek4j34","display_name":"Minist\u00e8re de la Sant\u00e9","country_code":"DZ","type":"government","lineage":["https://openalex.org/I4210107631"]},"years":[2024]},{"institution":{"id":"https://openalex.org/I56067802","ror":"https://ror.org/015m7wh34","display_name":"Universit\u00e9 de Rennes","country_code":"FR","type":"education","lineage":["https://openalex.org/I56067802"]},"years":[2023]}],"last_known_institutions":[{"id":"https://openalex.org/I4210107631","ror":"https://ror.org/01qek4j34","display_name":"Minist\u00e8re de la Sant\u00e9","country_code":"DZ","type":"government","lineage":["https://openalex.org/I4210107631"]}],"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","count":5,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","count":5,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","count":2,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","count":1,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","count":1,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":2.35e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","value":2.01e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","value":1.32e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","value":5.9e-06,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","value":5.3e-06,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","score":0.6353718042373657},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.6312791109085083},{"id":"17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","score":0.5048592686653137},{"id":"144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","score":0.47541290521621704},{"id":"159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","score":0.0873345136642456}],"counts_by_year":[{"year":2022,"works_count":2,"oa_works_count":2,"cited_by_count":0},{"year":2023,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2024,"works_count":2,"oa_works_count":2,"cited_by_count":1}],"display_name_alternatives":["S Ghabri","Salah Ghabri"],"block_key":"s ghabri","works_api_url":"https://api.openalex.org/works?filter=author.id:A5009504781","awards_count":0,"updated_date":"2026-10-27T12:30:23","created_date":"2022-12-25T00:00:00"}